BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22582186)

  • 21. The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values?
    Chrostek L; Cylwik B; Gruszewska E; Tobolczyk J
    Alcohol; 2012 Feb; 46(1):69-73. PubMed ID: 21943926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.
    DiMartini A; Day N; Lane T; Beisler AT; Dew MA; Anton R
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1729-33. PubMed ID: 11781505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.
    Imbert-Bismut F; Naveau S; Morra R; Munteanu M; Ratziu V; Abella A; Messous D; Thabut D; Benhamou Y; Poynard T
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):18-27. PubMed ID: 19011575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carbohydrate-deficient transferrin and liver diseases. Study of 94 patients].
    Ouyahya F; Bacq Y; Schellenberg F; Metman EH; Weill J
    Gastroenterol Clin Biol; 1995; 19(8-9):698-702. PubMed ID: 8522119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of carbohydrate-deficient transferrin (CDT) in the assessment of abuse and abstinence in chronic alcoholism].
    Avivar Falcón I; Rubio Rubio JM; Leal Luna A; González Vilches J; del Trigo Espinosa MA
    An Med Interna; 2000 Nov; 17(11):572-5. PubMed ID: 11322028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Personal experience with determination of carbohydrate-deficient transferrin].
    Stejskal D; Vavrousková J; Franková M; Jedelský L; Horalík D; Pastorková R
    Vnitr Lek; 1999 Jun; 45(6):347-52. PubMed ID: 11045170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum level of carbohydrate-deficient transferrin as a marker of alcoholic liver disease.
    Yamauchi M; Hirakawa J; Maezawa Y; Nishikawa F; Mizuhara Y; Ohata M; Nakajima H; Toda G
    Alcohol Alcohol Suppl; 1993; 1B():3-8. PubMed ID: 8003126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between acetaldehyde-modified haemoglobin, carbohydrate-deficient transferrin (CDT) and haematological abnormalities in chronic alcoholism.
    Wickramasinghe SN; Corridan B; Hasan R; Marjot DH
    Alcohol Alcohol; 1994 Jul; 29(4):415-23. PubMed ID: 7986279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical evaluation of a new capillary electrophoresis method for carbohydrate-deficient transferrin measurement.
    Schellenberg F; Girre C; Nalpas B; Plat A; Tome A; Pagès JC
    Clin Chim Acta; 2007 Jul; 382(1-2):48-53. PubMed ID: 17467678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical performance of the carbohydrate-deficient transferrin (CDT) assay by the Sebia Capillarys2 system in case of cirrhosis. Interest of the Bio-Rad %CDT by HPLC test and Siemens N-Latex CDT kit as putative confirmatory methods.
    Gonzalo P; Pecquet M; Bon C; Gonzalo S; Radenne S; Augustin-Normand C; Souquet JC
    Clin Chim Acta; 2012 Apr; 413(7-8):712-8. PubMed ID: 22244929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of carbohydrate-deficient transferrin and trypsin activity in the diagnosis of acute alcoholic pancreatitis.
    Aparicio JR; Viedma JA; Aparisi L; Navarro S; Martínez J; Pérez-Mateo M
    Am J Gastroenterol; 2001 Jun; 96(6):1777-81. PubMed ID: 11419828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of diagnostic validity of carbohydrate-deficient transferrin and other laboratory markers in chronic ethanol abuse].
    Moravcová E; Bednarík J; Dastych M; Novotná H; Pokora J
    Cas Lek Cesk; 2004; 143(1):39-43. PubMed ID: 15061118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Carbohydrate-Deficient Transferrin in Pancreatic Diseases of Different Etiologies.
    Cylwik B; Gruszewska E; Gudowska M; Lipartowska-Klimuk K; Szmitkowski M; Kedra B; Chrostek L
    Clin Lab; 2016 Sep; 62(9):1787-1793. PubMed ID: 28164578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False positive carbohydrate-deficient transferrin results in chronic hemodialysis patients related to the analytical methodology.
    Wolff F; Mesquita M; Corazza F; Demulder A; Willems D
    Clin Biochem; 2010 Sep; 43(13-14):1148-51. PubMed ID: 20599878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease.
    Stadheim LM; O'Brien JF; Lindor KD; Gores GJ; McGill DB
    Mayo Clin Proc; 2003 Jun; 78(6):703-7. PubMed ID: 12934779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron.
    De Feo TM; Fargion S; Duca L; Mattioli M; Cappellini MD; Sampietro M; Cesana BM; Fiorelli G
    Hepatology; 1999 Mar; 29(3):658-63. PubMed ID: 10051465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.